menu
    • menu

    Company profile for ITF Therapeutics

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    ITF Therapeutics is the U.S.-based rare disease division of Italfarmaco S.p.A., a global pharmaceutical company with a legacy of innovation since 1938. Operating in over 90 countries, Italfarmaco has developed numerous therapeutic products addressing unmet medical needs. Launched in January 2024, ITF Therapeutics focuses on developing and commercializing treatments for rare diseases. Committed to collaboration, we partner with...
    ITF Therapeutics is the U.S.-based rare disease division of Italfarmaco S.p.A., a global pharmaceutical company with a legacy of innovation since 1938. Operating in over 90 countries, Italfarmaco has developed numerous therapeutic products addressing unmet medical needs. Launched in January 2024, ITF Therapeutics focuses on developing and commercializing treatments for rare diseases. Committed to collaboration, we partner with patient advocacy and treatment communities to ensure our programs align with their needs, advancing impactful solutions for rare disease patients.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    ITF TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    300 Baker Avenue, Suite 280 Concord, MA 01742
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://itftherapeutics.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/itf-therapeutics/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Clinical Outsourcing

    Clinical Outsourcing

    Not Confirmed

    envelop Contact Supplier

    Clinical Outsourcing

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    ITF Therapeutics Reveals Multiple Data At 2026 MDA Conference
    ITF Therapeutics Reveals Multiple Data At 2026 MDA Conference

    23 Feb 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/itf-therapeutics-llc-announces-multiple-data-presentations-at-2026-mda-clinical-and-scientific-conference-302694089.html

    PR NEWSWIRE
    23 Feb 2026
    Share Share
    Givinostat Data Revealed For Duchenne Muscular Dystrophy At 2025
    Givinostat Data Revealed For Duchenne Muscular Dystrophy At 2025

    26 Sep 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/new-data-presented-on-givinostat-for-treatment-of-duchenne-muscular-dystrophy-at-2025-neuromuscular-study-group-annual-scientific-meeting-302567931.html

    PR NEWSWIRE
    26 Sep 2025
    Share Share
    ITF Therapeutics Publishes Positive Long-Term Data on Givinostat
    ITF Therapeutics Publishes Positive Long-Term Data on Givinostat

    25 Aug 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/itf-therapeutics-announces-publication-of-positive-long-term-data-reinforcing-givinostat-efficacy-and-safety-as-a-treatment-for-duchenne-muscular-dystrophy-302537372.html

    PR NEWSWIRE
    25 Aug 2025
    Share Share
    ITF Therapeutics LLC Opens New U.S. HQ in Concord, Massachusetts
    ITF Therapeutics LLC Opens New U.S. HQ in Concord, Massachusetts

    05 Mar 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/itf-therapeutics-llc-announces-opening-of-new-us-headquarters-in-concord-massachusetts-302393162.html

    PR NEWSWIRE
    05 Mar 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search